dc.description.abstract |
Background. African countries with limited healthcare capacity are particularly vulnerable to the novel coronavirus (COVID‑19). The
pandemic has left health systems short on resources to safely manage patients and protect healthcare workers. South Africa (SA) is still
battling the epidemic of HIV/AIDS and tuberculosis (TB), which had their programme/services interrupted due to the effects of the
pandemic. Lessons learnt from the HIV/AIDS and TB programme have shown that South Africans delay seeking health services when a
new disease presents itself.
Objective. To investigate the risk factors for COVID‑19 inpatients’ mortality within 24 hours of hospital admission in public health facilities
in Limpopo Province, SA.
Methods. The study used retrospective secondary data obtained from the 1 067 clinical records of patients admitted between March 2020
and June 2021 by the Limpopo Department of Health (LDoH). A multivariable logistic regression model, both adjusted and unadjusted,
was used to assess the risk factors associated with COVID‑19 mortality within 24 hours of admission.
Results. This study, which was conducted in Limpopo public hospitals, discovered that 411 COVID‑19 patients (40%) died within 24 hours
of admission. The majority of the patients were aged ≥60 years, mostly of female gender, and had comorbidities. In terms of vital signs, most
had body temperatures <38°C. Our study findings revealed that COVID‑19 patients who present with fever and shortness of breath were
1.8 and 2.5 times more likely to die within 24 hours of admission to the hospital, respectively, than patients without fever and with normal
respiratory rate. Hypertension was independently associated with mortality in COVID‑19 patients within 24 hours of admission, with a
high odds ratio (OR) for hypertensive patients (OR 1.451; 95% confidence interval 1.013 - 2.078) compared with non-hypertensive patients.
Conclusion. Assessing demographic and clinical risk factors for COVID‑19 mortality within 24 hours of admission aids in understanding
and prioritising patients with severe COVID‑19 and hypertension. Finally, this will provide guidelines for planning and optimising the use
of LDoH healthcare resources, and also aid in public awareness endeavours. |
en_US |